Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (281-290 of 506) with videos related to

Pageof 51
Sort By:
Arthritis Research & Therapy|May 20, 2015
A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosisRoberta Goncalves Marangoni, Benjamin D Korman, Yannick Allanore, et al.
Annals of the Rheumatic Diseases|February 24, 2018
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's diseaseCem Gabay, Bruno Fautrel, Jürgen Rech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Infections in 252 patients with common variable immunodeficiencyEric Oksenhendler, Laurence Gérard, Claire Fieschi, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
Plos One|May 16, 2018
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosisDavid Launay, David Montani, Paul M Hassoun, et al.
Journal of Clinical Immunology|June 2, 2018
Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency PatientsBoris Bienvenu, Grégoire Cozon, Yves Mataix, et al.
Rheumatology (Oxford, England)|February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.
Annals of the Rheumatic Diseases|April 9, 2011
Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factorPhilippe Dieudé, Catherine Boileau, Mickael Guedj, et al.
Autoimmunity Reviews|December 16, 2019
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR databaseCamelia Frantz, Dorte Huscher, Jérôme Avouac, et al.
Pageof 51

Showing results (281-290 of 506) with videos related to

Sort By:
Pageof 51
Arthritis Research & Therapy|May 20, 2015
A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosisRoberta Goncalves Marangoni, Benjamin D Korman, Yannick Allanore, et al.
Annals of the Rheumatic Diseases|February 24, 2018
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's diseaseCem Gabay, Bruno Fautrel, Jürgen Rech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Infections in 252 patients with common variable immunodeficiencyEric Oksenhendler, Laurence Gérard, Claire Fieschi, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
Plos One|May 16, 2018
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosisDavid Launay, David Montani, Paul M Hassoun, et al.
Journal of Clinical Immunology|June 2, 2018
Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency PatientsBoris Bienvenu, Grégoire Cozon, Yves Mataix, et al.
Rheumatology (Oxford, England)|February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.
Annals of the Rheumatic Diseases|April 9, 2011
Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factorPhilippe Dieudé, Catherine Boileau, Mickael Guedj, et al.
Autoimmunity Reviews|December 16, 2019
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR databaseCamelia Frantz, Dorte Huscher, Jérôme Avouac, et al.
Pageof 51